These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 25746201)
1. Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans. Borggren M; Nielsen J; Bragstad K; Karlsson I; Krog JS; Williams JA; Fomsgaard A Hum Vaccin Immunother; 2015; 11(8):1983-90. PubMed ID: 25746201 [TBL] [Abstract][Full Text] [Related]
2. A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs. Borggren M; Nielsen J; Karlsson I; Dalgaard TS; Trebbien R; Williams JA; Fomsgaard A Vaccine; 2016 Jul; 34(32):3634-40. PubMed ID: 27211039 [TBL] [Abstract][Full Text] [Related]
3. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection. Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of a polyvalent influenza DNA vaccine in pigs. Karlsson I; Borggren M; Rosenstierne MW; Trebbien R; Williams JA; Vidal E; Vergara-Alert J; Foz DS; Darji A; Sisteré-Oró M; Segalés J; Nielsen J; Fomsgaard A Vet Immunol Immunopathol; 2018 Jan; 195():25-32. PubMed ID: 29249314 [TBL] [Abstract][Full Text] [Related]
5. DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs. Gorres JP; Lager KM; Kong WP; Royals M; Todd JP; Vincent AL; Wei CJ; Loving CL; Zanella EL; Janke B; Kehrli ME; Nabel GJ; Rao SS Clin Vaccine Immunol; 2011 Nov; 18(11):1987-95. PubMed ID: 21918118 [TBL] [Abstract][Full Text] [Related]
6. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300 [TBL] [Abstract][Full Text] [Related]
7. DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs. Sisteré-Oró M; López-Serrano S; Veljkovic V; Pina-Pedrero S; Vergara-Alert J; Córdoba L; Pérez-Maillo M; Pleguezuelos P; Vidal E; Segalés J; Nielsen J; Fomsgaard A; Darji A PLoS One; 2019; 14(9):e0222201. PubMed ID: 31553755 [TBL] [Abstract][Full Text] [Related]
8. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973 [TBL] [Abstract][Full Text] [Related]
9. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants. Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604 [TBL] [Abstract][Full Text] [Related]
10. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs. Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697 [TBL] [Abstract][Full Text] [Related]
12. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. Heinen PP; Rijsewijk FA; de Boer-Luijtze EA; Bianchi ATJ J Gen Virol; 2002 Aug; 83(Pt 8):1851-1859. PubMed ID: 12124449 [TBL] [Abstract][Full Text] [Related]
13. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model. Shen X; Söderholm J; Lin F; Kobinger G; Bello A; Gregg DA; Broderick KE; Sardesai NY Vaccine; 2012 Nov; 30(48):6946-54. PubMed ID: 22406460 [TBL] [Abstract][Full Text] [Related]
14. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs. Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090 [TBL] [Abstract][Full Text] [Related]
15. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706 [TBL] [Abstract][Full Text] [Related]
16. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. Wesley RD; Lager KM Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice. Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs. Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice. Tan L; Lu H; Zhang D; Wang K; Tian M; Liu C; Liu Y; Hu B; Jin N Sci China Life Sci; 2011 Apr; 54(4):293-9. PubMed ID: 21416231 [TBL] [Abstract][Full Text] [Related]
20. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]